PBPK Modeling and quantitative in vitro-in vivo extrapolations

Course PBPK Modeling and quantitative in vitro-in vivo extrapolations

Physiologically based pharmacokinetic (PBPK) modelling plays a crucial role in next generation (non-animal) risk evaluations to inform the design of in vitro studies and to convert the data obtained with in vitro models into human dose−response or potency information. The goal of the course is to acquaint participants with setting up PBPK models based on non-animal input parameters and to subsequently use these models to extrapolate in vitro bioassay data to human dose-response or potency information.

Date And Time

Thu, Oct 3, 2019, 9:00 AM –Fri, Oct 4, 2019, 5:00 PM CEST

Location

Wageningen Food Safety Research
Akkermaalsbos 2
6708 Wageningen

The course consists of:

  • Lectures that cover the basic principles of PBPK model-development and the application of PBPK modelling in different fields (e.g. safety evaluations of pharmaceuticals and industrial chemicals, development of alternatives to animal testing).
  • Hands-on experience focussing on how to derive adequate chemical-specific input parameters.
  • Hands-on experience with developing PBPK models in Berkeley Madonna software.
  • Hands-on experience with developing PBPK models with Simcyp’s Population-based Simulator.
  • Use of the models to extrapolate in vitro bioassay results to human dose-response or potency information